These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25257526)

  • 41. In-silico designing and characterization of binding modes of two novel inhibitors for CB1 receptor against obesity by classical 3D-QSAR approach.
    Khan N; Halim SA; Khan W; Zafar SK; Ul-Haq Z
    J Mol Graph Model; 2019 Jun; 89():199-214. PubMed ID: 30908997
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural determinants of benzodiazepinedione/peptide-based p53-HDM2 inhibitors using 3D-QSAR, docking and molecular dynamics.
    Wang F; Li Y; Ma Z; Wang X; Wang Y
    J Mol Model; 2012 Jan; 18(1):295-306. PubMed ID: 21523548
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design of new CD38 inhibitors based on CoMFA modelling and molecular docking analysis of 4‑amino-8-quinoline carboxamides and 2,4-diamino-8-quinazoline carboxamides.
    Sepehri B; Ghavami R
    SAR QSAR Environ Res; 2019 Jan; 30(1):21-38. PubMed ID: 30489181
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insight into the interaction mechanism of human SGLT2 with its inhibitors: 3D-QSAR studies, homology modeling, and molecular docking and molecular dynamics simulations.
    Dong L; Feng R; Bi J; Shen S; Lu H; Zhang J
    J Mol Model; 2018 Mar; 24(4):86. PubMed ID: 29511885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In silico QSAR studies of anilinoquinolines as EGFR inhibitors.
    Pasha FA; Muddassar M; Srivastava AK; Cho SJ
    J Mol Model; 2010 Feb; 16(2):263-77. PubMed ID: 19590909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insight into the Structural Determinants of Imidazole Scaffold-Based Derivatives as TNF-α Release Inhibitors by in Silico Explorations.
    Wang Y; Wu M; Ai C; Wang Y
    Int J Mol Sci; 2015 Aug; 16(9):20118-38. PubMed ID: 26307982
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure based 3D-QSAR studies of Interleukin-2 inhibitors: Comparing the quality and predictivity of 3D-QSAR models obtained from different alignment methods and charge calculations.
    Halim SA; Zaheer-ul-Haq
    Chem Biol Interact; 2015 Aug; 238():9-24. PubMed ID: 26051521
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Melanin-Concentrating Hormone Receptor 1 Antagonists Lacking an Aliphatic Amine: Synthesis and Structure-Activity Relationships of Novel 1-(Imidazo[1,2-a]pyridin-6-yl)pyridin-2(1H)-one Derivatives.
    Igawa H; Takahashi M; Kakegawa K; Kina A; Ikoma M; Aida J; Yasuma T; Kawata Y; Ashina S; Yamamoto S; Kundu M; Khamrai U; Hirabayashi H; Nakayama M; Nagisa Y; Kasai S; Maekawa T
    J Med Chem; 2016 Feb; 59(3):1116-39. PubMed ID: 26736071
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Probing structural features and binding mode of 3-arylpyrimidin-2,4-diones within housefly γ-aminobutyric acid (GABA) receptor.
    Li Q; Zhang L; Ma Z; Kong X; Wang F; Zhang H; Wang Y
    Int J Mol Sci; 2011; 12(9):6293-311. PubMed ID: 22016659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In silico studies and fluorescence binding assays of potential anti-prion compounds reveal an important binding site for prion inhibition from PrP(C) to PrP(Sc).
    Pagadala NS; Perez-Pineiro R; Wishart DS; Tuszynski JA
    Eur J Med Chem; 2015 Feb; 91():118-31. PubMed ID: 25042003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies of H4R antagonists using 3D-QSAR, molecular docking and molecular dynamics.
    Liu J; Li Y; Zhang HX; Zhang SW; Yang L
    J Mol Model; 2012 Mar; 18(3):991-1001. PubMed ID: 21647664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-obesity effects of small molecule melanin-concentrating hormone receptor 1 (MCHR1) antagonists.
    Luthin DR
    Life Sci; 2007 Jul; 81(6):423-40. PubMed ID: 17655875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predicting anti-cancer activity of quinoline derivatives: CoMFA and CoMSIA approach.
    Vaidya A; Jain AK; Kumar P; Kashaw SK; Agrawal RK
    J Enzyme Inhib Med Chem; 2011 Dec; 26(6):854-61. PubMed ID: 21476832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Probing the binding mechanism of substituted pyridine derivatives as effective and selective lysine-specific demethylase 1 inhibitors using 3D-QSAR, molecular docking and molecular dynamics simulations.
    Wang ZZ; Yang J; Sun XD; Ma CY; Gao QB; Ding L; Liu HM
    J Biomol Struct Dyn; 2019 Aug; 37(13):3482-3495. PubMed ID: 30175693
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular docking, molecular dynamics simulations and QSAR studies on some of 2-arylethenylquinoline derivatives for inhibition of Alzheimer's amyloid-beta aggregation: Insight into mechanism of interactions and parameters for design of new inhibitors.
    Safarizadeh H; Garkani-Nejad Z
    J Mol Graph Model; 2019 Mar; 87():129-143. PubMed ID: 30537643
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined 3D-QSAR, molecular docking, and molecular dynamics study on piperazinyl-glutamate-pyridines/pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation.
    Hao M; Li Y; Wang Y; Yan Y; Zhang S; Li G; Yang L
    J Chem Inf Model; 2011 Oct; 51(10):2560-72. PubMed ID: 21923153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and evaluation of 2-amino-8-alkoxy quinolines as MCHr1 antagonists. Part 1.
    Souers AJ; Wodka D; Gao J; Lewis JC; Vasudevan A; Gentles R; Brodjian S; Dayton B; Ogiela CA; Fry D; Hernandez LE; Marsh KC; Collins CA; Kym PR
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4873-7. PubMed ID: 15341942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In silico studies on p21-activated kinase 4 inhibitors: comprehensive application of 3D-QSAR analysis, molecular docking, molecular dynamics simulations, and MM-GBSA calculation.
    Gao Y; Wang H; Wang J; Cheng M
    J Biomol Struct Dyn; 2020 Sep; 38(14):4119-4133. PubMed ID: 31556340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel MCH1 receptor antagonists: a patent review.
    Johansson A; Löfberg C
    Expert Opin Ther Pat; 2015 Feb; 25(2):193-207. PubMed ID: 25522065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The three dimensional Quantitative Structure Activity Relationships (3D-QSAR) and docking studies of curcumin derivatives as androgen receptor antagonists.
    Xu G; Chu Y; Jiang N; Yang J; Li F
    Int J Mol Sci; 2012; 13(5):6138-6155. PubMed ID: 22754355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.